HORIBA Medical is proud to announce that its Yumizen H500 benchtop hematology analyzer has won the Best New Clinical Instrumentation Award for 2022 at the Scientists' Choice Awards®. HORIBA's Yumizen H500 is a compact analyzer with enhanced performance, new features, and increased benefits which all contributed to its award-winning votes. The instrument is designed for small laboratories and is ideal for use in a variety of clinical laboratory environments and point-of-care (POC) settings, or for anyone looking to upgrade from a 3-part to a 5-part differential technology solution.
HORIBA received the award for the Yumizen H500 during a special ceremony at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo. Each year, clinical scientists and clinicians from around the world are invited to participate in these awards by nominating, reviewing, and voting for the laboratory products that have had the greatest impact on their work.
The Yumizen H500 was recognized for ensuring safe and easy diagnosis by delivering timely and reliable results in many locations. With just three reagents, making it a sustainable option, and an intuitive touch screen user interface, it is designed for ease-of-use. Yet, it offers 37 parameters, including: full 5-part WBC differential, immature WBCs, digital red blood cell parameters, and platelet parameters, as well as a malaria and dengue flagging option.
Requiring a sample of 20 µL whole blood and an analysis time of just 60 seconds, the Yumizen H500 is a highly flexible solution for rapid blood analysis in a multitude of situations, including POC settings for pediatric care, oncology units and drug monitoring services. UK-based independent evaluation studies have confirmed its capabilities in such POC settings, demonstrating exceptional correlation with larger laboratory-based hematology analyzers.
Content adapted from HORIBA Medical's official announcement. For availability in Turkey, please contact Medomer.
Source: HORIBA Medical — This content is adapted from a HORIBA Medical press release. All brand and product names belong to their respective owners.
